NCT04424147
- Conditions
- Bone Marrow Diseases, HVA Regimen, Hematologic Diseases, +11 more
- Locations
-
- Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
Clinical trial condition
Leukemia
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
4,430 public trials
1,038 recruiting studies
Leukemia trial results
NCT01586455
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
- Locations
-
- Children's Hospital Colorado Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States
- University of Utah Salt Lake City, Utah, United States
NCT01475110
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukaemia, +11 more
- Locations
-
- Centro Oncologico Basilicata Rionero in Vulture, Potenza, Italy
- Ospedale Alessandria, Italy
- S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
- S.G. Moscati Hospital Avellino, Italy
NCT01842672
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +26 more
- Locations
-
- New York Medical College Valhalla, New York, United States
- Levine Children's Hospital Charlotte, North Carolina, United States
NCT01736683
- Conditions
- Anemia, Bone Marrow Diseases, Chronic Disease, +16 more
- Locations
-
- Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Baltimore, Maryland, United States
- Dana-Farber / Harvard Cancer Institute Boston, Massachusetts, United States
NCT02013128
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
- Locations
-
- TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
- TG Therapeutics Investigational Trial Site Tucson, Arizona, United States
- TG Therapeutics Investigational Trial Site Santa Barbara, California, United States
- TG Therapeutics Investigational Trial Site Boulder, Colorado, United States
NCT03349281
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT02535286
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- TG Therapeutics Investigational Trial Site New York, United States
- TG Therapeutics Investigational Trial Site Durham, North Carolina, United States
- TG Therapeutics Investigational Trial Site Philadelphia, Pennsylvania, United States
- TG Therapeutics Investigational Trial Site Seattle, Washington, United States
NCT02581917
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
Completed
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
NCT01700673
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States